Keywords: Neurotransmission, Neuro, pharmacological MRI, functional MRS
Motivation: An integrated imaging approach using functional magnetic resonance imaging (fMRI) and functional proton magnetic resonance spectroscopy (fMRS) can increase our understanding of the functional response to antidepressant medication like es-ketamine.
Goal(s): We aimed to assess the dose- and time-dependent effects of the antidepressant es-ketamine on the functional brain response.
Approach: We used an interleaved fMRI and fMRS experiment to assess whole-brain changes in BOLD signal and neurometabolite changes in the anterior cingulate cortex.
Results: Es-ketamine increased glutamate levels and the BOLD signal, and decreased aspartate and glucose levels in the first 10-15 minutes following administration, with specific dose-dependent effects.
Impact: Our results show both dose- and time-dependent neurometabolic and hemodynamic responses to es-ketamine. Understanding the contribution of these two determinants of the functional response might advance our understanding of the effects of antidepressant medication on the human brain.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords